Protecting children from nerve agents
Published: October 4,2013
By Wally Northway
While Mississippi State University scientists work on an antidote for nerve agents for use by the military, the federal government is looking for nerve agent treatments for children.
According to a release from the U.S. Department of Health and Human Services, an effective, faster-acting and longer-lasting pediatric medication to treat seizures caused by nerve agents will be studied and purchased under a Project BioShield contract from HHS’ Office of the Assistant Secretary for Preparedness and Response.
There are no currently approved medications to treat seizures caused by nerve agents, HHS reports.
Under a five-year, $60-million contract, Meridian Medical Technologies Inc. of Columbia, Md., a Pfizer company, will conduct studies of midazolam to seek approval from the U.S. Food and Drug Administration for the drug’s use in treating seizures caused by nerve agents. Meridian also will seek FDA approval of a midazolam auto-injector for children and adults, and seek approval of midazolam for use in treating common prolonged seizures.
To sign up for Mississippi Business Daily Updates, click here.
One Response to “Protecting children from nerve agents”
Mississippi Economic Council
Mississippi Chambers of Commerce
Mississippi State Legislature
Mississippi Development Authority
Mississippi Economic Development Council
North Mississippi News
Social Security Disability Lawyer
Auto Accidents Lawyer
Top Posts & Pages
- Comstock quits Tuscaloosa play on falling prices
- Clinton office complex sold for $20.5 million
- Meadville mayor seeks Sojourner's Senate seat
- Entergy plans three solar-power pilot projects
- Shale oil: market correction or longterm direction?
- PHIL HARDWICK: Characteristics of a good year-end fundraising letter
- Record soybean yield is valued at $1.17 billion
- MARTIN WILLOUGHBY: Gary Herring building tomorrow by educating today
- Miss. surgeon sentenced in tax evasion case